|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.17 CNY | -1.85% |
|
-10.79% | -3.31% |
| 04-19 | KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-17 | Kunyao Group Receives Clinical Trial Approval for FMF Drug | MT |
KPC Pharmaceuticals, Inc. approved the resignation of Liu Huijiang as a director and appointment of Li Shuangyou as director of the company at its seventh directorate meeting held on July 6, 2015.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.31% | 2.11B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
KPC PHARMACEUTICALS,INC 
